arrow
G

Giada Targato

University of Udine
H指数:10
被引数:521

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Differential dynamics of fragmentomic and epigenetic circulating tumor DNA (ctDNA) features in first-line Palbociclib and Ribociclib treatment for Hormone Receptor (HR) positive, HER2 negative metastatic breast cancer (MBC)
2024-05-020
PRE
Unraveling the influence of progesterone receptor status on endocrine therapy sensitivity: insight from epigenetic and fragmentomics ctDNA profiling in estrogen receptor positive, HER2 negative metastatic breast cancer (MBC)
2024-05-020
PRE
Patterns of time-to-progression intervals across clinical and liquid biopsy (LB) features in hormone receptor-positive (HR+) HER2-negative (HER2-) metastatic breast cancer (MBC) patients (pts) treated with first-line endocrine therapy (ET)
2023-10-010
OA
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup
2023-07-015
PRE
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancerdresults from an international, multicenter analysis coordinated by the AGMT Study Group
2023-02-0110
OAAI
Post-progression outcomes of NSCLC patients with PD-L1 expression > 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study

在一项大型多中心真实世界研究中接受一线单药pembrolizumab治疗的PD-L1表达> 50% 的NSCLC患者的进展后结局

2021-05-0120
OAAI
Plasma-Based Longitudinal Evaluation ofESR1Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

基于血浆的激素受体阳性HER2-Negative转移性乳腺癌esr1表观遗传状态的纵向评估

2020-09-1821
OAAI